Sitagliptin added to ongoing treatment with metformin improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)

被引：0

|

作者：

Kadowaki, Takashi

Tajima, Naoko

Odawara, Masato

Nishii, Mikio

Nonaka, Kenji

Stein, Peter P.

机构：

来源：

DIABETES | 2008年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A589 / A590

页数：2

相关论文

共 50 条

[41] Saxagliptin (SAXA) Reduces A1C and Is Well Tolerated in Patients With Type 2 Diabetes (T2DM) and Albuminuria
Bonora, Enzo
Cook, William
Bryzinski, Brian
Hirshberg, Boaz
Allen, Elsie
DIABETES, 2013, 62 : A669 - A669
[42] Empagliflozin as Add-On to Metformin Plus Sulfonylurea (SU) for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
Haering, Hans-Ulrich
Merker, Ludwig
Seewaldt-Becker, Elke
Weimer, Marc
Meinicke, Thomas
Woerle, Hans J.
Broedl, Uli C.
DIABETES, 2013, 62 : A279 - A279
[43] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
Kosmalski, M.
Drozdowska, A.
Sliwinska, A.
Drzewoski, J.
ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
[44] GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA
Monti, C., I
VALUE IN HEALTH, 2017, 20 (09) : A919 - A919
[45] Addition of Sitagliptin, an Oral, Highly-Selective Dipeptidyl Peptidase-4 Inhibitor, Improved Glycemic Control and Was Well Tolerated in Japanese Patients with Type 2 Diabetes on Insulin Monotherapy
Kadowaki, Takashi
Tajima, Naoko
Odawara, Masato
Minamide, Toshiomi
Kawashima, Masaru
Yanagida, Daisuke
Taniguchi, Tadaaki
Ferreira, Juan Camilo Arjona
DIABETES, 2011, 60 : A279 - A280
[46] The Addition of Sitagliptin to Metformin and Pioglitazone Therapy Enhances Glycemic Control in Patients with Type 2 Diabetes
Fonseca, Vivian
Staels, Bart
Morgan, Jerry D., II
Yue Shentu
Golm, Gregory T.
Johnson-Levonas, Amy O.
Kaufman, Keith D.
Goldstein, Barry J.
Steinberg, Helmut
Henry, Robert
DIABETES, 2011, 60 : A308 - A308
[47] The effects of gastric electrical stimulation (TANTALUS®) on glycemic control in obese patients with type 2 diabetes (T2DM)
Bohdjalian, Arthur
Rosak, Ch
Jung, R.
Schramm, M.
Weiner, R.
Ludvik, B.
Prager, G.
OBESITY SURGERY, 2007, 17 (08) : 1055 - 1055
[48] Sitagliptin (SITA) Provides Similar Glycemic Control with Weight Loss and Less Hypoglycemia Compared to Sulfonylurea (SU) in Older Patients with Type 2 Diabetes (T2DM)
Seck, Thomas
Engel, Samuel S.
Chen, Yu
Golm, Gregory T.
Davies, Michael J.
Kaufman, Keith D.
Goldstein, Barry
DIABETES, 2011, 60 : A620 - A621
[49] Sitagliptin improved beta-cell function in patients with type 2 diabetes (T2DM): A model-based analysis
Xu, Lei
Man, Chiara Dalla
Cobelli, Claudio
Williams-Herman, Debora
Meininger, Gary
Khatami, Hootan
Stein, Peter
DIABETES, 2006, 55 : A466 - A466
[50] The DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM) inadequately treated with metformin
Ahren, B
Gomis, R
Mills, D
Schweizer, A
DIABETES, 2004, 53 : A83 - A83

← 1 2 3 4 5 →